BG108450A - Aromatic dicarboxylic acid derivatives - Google Patents

Aromatic dicarboxylic acid derivatives

Info

Publication number: BG108450A
Authority: BG; Bulgaria
Prior art keywords: dicarboxylic acid; acid derivatives; aromatic dicarboxylic; compounds; administered
Prior art date: 2001-06-15

Application number

BG108450A

Other languages

Bulgarian (bg)

English (en)

Inventor

Ulrike Laser-Reiff

Tim Sattelkau

Gerd Zimmermann

Original Assignee

F.Hoffmann - La Roche Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-06-15

Filing date

2003-12-15

Publication date

2005-01-31

2003-12-15 Application filed by F.Hoffmann - La Roche Ag filed Critical F.Hoffmann - La Roche Ag

2005-01-31 Publication of BG108450A publication Critical patent/BG108450A/xx

Links

-1 Aromatic dicarboxylic acid derivatives Chemical class 0.000 title abstract 2
150000001875 compounds Chemical class 0.000 abstract 2
206010028980 Neoplasm Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
229940121372 histone deacetylase inhibitor Drugs 0.000 abstract 1
239000003276 histone deacetylase inhibitor Substances 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/10—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to carbon atoms of six-membered aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
- C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/16—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with acylated ring nitrogen atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/14—Radicals substituted by nitrogen atoms not forming part of a nitro radical
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/58—Radicals substituted by nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Pyridine Compounds (AREA)

BG108450A 2001-06-15 2003-12-15 Aromatic dicarboxylic acid derivatives BG108450A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP01114496		2001-06-15

Publications (1)

Publication Number	Publication Date
BG108450A true BG108450A (en)	2005-01-31

Family

ID=8177731

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BG108450A BG108450A (en)	2001-06-15	2003-12-15	Aromatic dicarboxylic acid derivatives

Country Status (32)

Country	Link
US (2)	US6784173B2 (cs)
EP (1)	EP1401824B1 (cs)
JP (1)	JP4195377B2 (cs)
KR (2)	KR100910958B1 (cs)
CN (1)	CN1271066C (cs)
AR (1)	AR036055A1 (cs)
AT (1)	ATE343569T1 (cs)
AU (1)	AU2002355626B2 (cs)
BG (1)	BG108450A (cs)
BR (1)	BR0210424A (cs)
CA (1)	CA2449804A1 (cs)
CO (1)	CO5540280A2 (cs)
CZ (1)	CZ200425A3 (cs)
DE (1)	DE60215652T2 (cs)
EC (1)	ECSP034896A (cs)
ES (1)	ES2272800T3 (cs)
GT (1)	GT200200121A (cs)
HR (1)	HRP20031019A2 (cs)
HU (1)	HUP0401233A3 (cs)
IL (1)	IL159097A0 (cs)
MA (1)	MA27041A1 (cs)
MX (1)	MXPA03011501A (cs)
NO (1)	NO20035555D0 (cs)
NZ (1)	NZ529874A (cs)
PA (1)	PA8548001A1 (cs)
PE (1)	PE20030086A1 (cs)
PL (1)	PL366729A1 (cs)
RS (1)	RS98203A (cs)
RU (1)	RU2289580C2 (cs)
SK (1)	SK172004A3 (cs)
WO (1)	WO2003011851A2 (cs)
ZA (1)	ZA200309260B (cs)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6822267B1 (en) *	1997-08-20	2004-11-23	Advantest Corporation	Signal transmission circuit, CMOS semiconductor device, and circuit board
CA2476067C (en)	2002-03-13	2011-09-20	Janssen Pharmaceutica N.V.	Carbonylamino-derivatives as novel inhibitors of histone deacetylase
AU2003218737B2 (en) *	2002-03-13	2008-04-10	Janssen Pharmaceutica N.V.	Inhibitors of histone deacetylase
BR0308908A (pt) *	2002-04-03	2005-01-04	Topotarget Uk Ltd	Composto, composição, uso de um composto, e, métodos para inibir a hdac em uma célula, para o tratamento de uma condição mediada pela hdac, de um condição proliferativa, de câncer e de psorìase
US7154002B1 (en)	2002-10-08	2006-12-26	Takeda San Diego, Inc.	Histone deacetylase inhibitors
US7250514B1 (en)	2002-10-21	2007-07-31	Takeda San Diego, Inc.	Histone deacetylase inhibitors
TW200418825A (en) *	2002-12-16	2004-10-01	Hoffmann La Roche	Novel (R)-and (S) enantiomers of thiophene hydroxamic acid derivatives
TW200424174A (en)	2003-02-06	2004-11-16	Hoffmann La Roche	New TP diamide
US7208491B2 (en) *	2003-02-07	2007-04-24	Hoffmann-La Roche Inc.	N-monoacylated o-phenylenediamines
KR20050122210A (ko) *	2003-03-17	2005-12-28	다케다 샌디에고, 인코포레이티드	히스톤 탈아세틸화 효소 억제제
TW200424187A (en) *	2003-04-04	2004-11-16	Hoffmann La Roche	New oxime derivatives and their use as pharmaceutically active agents
US7935724B2 (en) *	2003-10-09	2011-05-03	Merck Hdac Research, Llc	Thiophene and benzothiophene hydroxamic acid derivatives
WO2005065681A1 (en) *	2003-12-19	2005-07-21	Takeda San Diego, Inc.	N- hydroxy-3-(3-(1h-imidazol-2-yl)-phenyl)-acrylamide derivatives and related compounds as histone deacetylase (hdac) inhibitors for the treatment of cancer
WO2005066151A2 (en) *	2003-12-19	2005-07-21	Takeda San Diego, Inc.	Histone deacetylase inhibitors
US7217723B2 (en)	2004-02-02	2007-05-15	Eisai Co., Ltd.	Heterocyclic compound having oxime group
US20050203081A1 (en) *	2004-02-25	2005-09-15	Jinbo Lee	Inhibitors of protein tyrosine phosphatase 1B
AR047894A1 (es) *	2004-02-25	2006-03-01	Wyeth Corp	Derivados de tiofeno como inhibidores de la proteina tirosina fosfatasa 1b (ptpasa 1b); metodos para su preparacion, composiciones farmaceuticas que los contienen y su uso en el tratamiento de enfermedades mediadas por ptpasa 1b
CN1980920A (zh) *	2004-06-14	2007-06-13	霍夫曼-拉罗奇有限公司	噻吩衍生物、它们的制备以及作为药剂的应用
JP2008501665A (ja) *	2004-06-14	2008-01-24	エフ．ホフマン−ラ　ロシュ　アーゲー	チオフェンヒドロキサム酸誘導体及びｈｄａｃ阻害剤としてのこれらの使用
CN1964963A (zh) *	2004-06-14	2007-05-16	霍夫曼-拉罗奇有限公司	异羟肟酸酯、它们的制备以及作为药剂的应用
PL1781639T3 (pl)	2004-07-28	2012-07-31	Janssen Pharmaceutica Nv	Podstawione pochodne indolilo-alkiloaminowe jako nowe inhibitory deacetylazy histonowej
KR100620488B1 (ko)	2004-08-13	2006-09-08	연세대학교 산학협력단	신규한 히스톤 디아세틸라아제 억제제 및 이의 제조방법
JP2008524246A (ja) *	2004-12-16	2008-07-10	タケダサンディエゴインコーポレイテッド	ヒストンデアセチラーゼ阻害剤
US20100087328A1 (en) *	2005-03-01	2010-04-08	The Regents Of The University Of Michigan	Brm expression and related diagnostics
WO2006094068A2 (en) *	2005-03-01	2006-09-08	The Regents Of The University Of Michigan	Hdac inhibitors that promote brm expression and brm related diagnostics
CN101163690A (zh) *	2005-04-20	2008-04-16	默克公司	苯并噻吩异羟肟酸衍生物
GB0509225D0 (en)	2005-05-05	2005-06-15	Chroma Therapeutics Ltd	Inhibitors of enzymatic activity
GB0509223D0 (en)	2005-05-05	2005-06-15	Chroma Therapeutics Ltd	Enzyme inhibitors
WO2006122319A2 (en) *	2005-05-11	2006-11-16	Takeda San Diego, Inc.	Histone deacetylase inhibitors
ZA200800901B (en) *	2005-07-14	2010-05-26	Takeda San Diego Inc	Histone deacetylase inhibitors
GB0518237D0 (en) *	2005-09-07	2005-10-19	Angeletti P Ist Richerche Bio	Therapeutic compounds
AR057579A1 (es) *	2005-11-23	2007-12-05	Merck & Co Inc	Compuestos espirociclicos como inhibidores de histona de acetilasa (hdac)
EP2338878A3 (en) *	2005-12-15	2011-11-16	Vicuron Pharmaceuticals, Inc.	N-hydroxyamide derivatives possessing antibacterial activity
WO2007084390A2 (en) *	2006-01-13	2007-07-26	Takeda San Diego, Inc.	Histone deacetylase inhibitors
JP5247470B2 (ja)	2006-01-19	2013-07-24	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	ヒストンデアセチラーゼのインヒビターとしてのピリジン及びピリミジン誘導体
GB0603041D0 (en) *	2006-02-15	2006-03-29	Angeletti P Ist Richerche Bio	Therapeutic compounds
GB0619753D0 (en)	2006-10-06	2006-11-15	Chroma Therapeutics Ltd	Enzyme inhibitors
JP5043120B2 (ja)	2006-10-30	2012-10-10	クロマセラピューティクスリミテッド	ヒストンデアセチラーゼの阻害剤としてのヒドロキサメート
GB0713686D0 (en) *	2007-07-13	2007-08-22	Addex Pharmaceuticals Sa	New compounds 2
CA2701115A1 (en) *	2007-10-04	2009-04-09	Merck Sharp & Dohme Corp.	N-hydroxy-naphthalene dicarboxamide and n-hydroxy-biphenyl-dicarboxamide compounds as histone deacetylase inhibitors
AU2009289649B2 (en)	2008-09-03	2016-05-05	Biomarin Pharmaceutical Inc.	Compositions including 6-aminohexanoic acid derivatives as HDAC inhibitors
GB0903480D0 (en)	2009-02-27	2009-04-08	Chroma Therapeutics Ltd	Enzyme Inhibitors
US10059723B2 (en)	2011-02-28	2018-08-28	Biomarin Pharmaceutical Inc.	Histone deacetylase inhibitors
JP6250403B2 (ja)	2011-02-28	2017-12-20	バイオマリンファーマシューティカルインク	ヒストン脱アセチル化酵素阻害剤
US8957066B2 (en)	2011-02-28	2015-02-17	Biomarin Pharmaceutical Inc.	Histone deacetylase inhibitors
PT2970139T (pt)	2013-03-15	2018-08-01	Biomarin Pharm Inc	Inibidores de hdac
EP2826769A1 (en)	2013-07-18	2015-01-21	Institut de Recherche pour le Développement ( IRD)	Compounds for the treatment and/or prevention of parasitic diseases and method of production thereof
KR101536050B1 (ko) *	2013-07-30	2015-07-13	충북대학교 산학협력단	신규 이사틴 기반 히드록삼산 및 이를 유효성분으로 포함하는 항암용 조성물
EP3062783B1 (en)	2013-10-18	2020-08-12	The General Hospital Corporation	Imaging histone deacetylases with a radiotracer using positron emission tomography
MX2016011833A (es) *	2014-03-12	2017-03-29	Chong Kun Dang Pharmaceutical Corp	Nuevos compuestos como inhibidores de histona desacetilasa 6 y composiciones farmaceuticas que los comprenden.
WO2019185413A1 (en)	2018-03-27	2019-10-03	Basf Se	Pesticidal substituted cyclopropyl derivatives
WO2024123700A1 (en) *	2022-12-05	2024-06-13	The General Hospital Corporation	Histone deacetylase inhibitors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3825554A (en) *	1969-06-13	1974-07-23	Atlantic Richfield Co	Method for preparing cyclic nitrile carbonates
JPS54148743A (en) *	1978-05-12	1979-11-21	Asahi Chem Ind Co Ltd	Production of methoclopramide
US5369108A (en) *	1991-10-04	1994-11-29	Sloan-Kettering Institute For Cancer Research	Potent inducers of terminal differentiation and methods of use thereof
US5700811A (en) *	1991-10-04	1997-12-23	Sloan-Kettering Institute For Cancer Research	Potent inducers of terminal differentiation and method of use thereof
US6174905B1 (en)	1996-09-30	2001-01-16	Mitsui Chemicals, Inc.	Cell differentiation inducer
AUPO721997A0 (en)	1997-06-06	1997-07-03	Queensland Institute Of Medical Research, The	Anticancer compounds
CA2391952C (en)	1999-11-23	2012-01-31	Methylgene Inc.	Inhibitors of histone deacetylase

2002
- 2002-06-11 US US10/167,677 patent/US6784173B2/en not_active Expired - Fee Related
- 2002-06-12 PA PA20028548001A patent/PA8548001A1/es unknown
- 2002-06-13 NZ NZ529874A patent/NZ529874A/xx unknown
- 2002-06-13 HU HU0401233A patent/HUP0401233A3/hu unknown
- 2002-06-13 KR KR1020037016358A patent/KR100910958B1/ko not_active Expired - Fee Related
- 2002-06-13 HR HR20031019A patent/HRP20031019A2/xx not_active Application Discontinuation
- 2002-06-13 AR ARP020102231A patent/AR036055A1/es unknown
- 2002-06-13 SK SK17-2004A patent/SK172004A3/sk unknown
- 2002-06-13 BR BR0210424-5A patent/BR0210424A/pt not_active IP Right Cessation
- 2002-06-13 AU AU2002355626A patent/AU2002355626B2/en not_active Ceased
- 2002-06-13 RS YUP-982/03A patent/RS98203A/sr unknown
- 2002-06-13 RU RU2003137578/04A patent/RU2289580C2/ru not_active IP Right Cessation
- 2002-06-13 EP EP02791436A patent/EP1401824B1/en not_active Expired - Lifetime
- 2002-06-13 CN CNB028120108A patent/CN1271066C/zh not_active Expired - Fee Related
- 2002-06-13 KR KR1020097010546A patent/KR20090059172A/ko not_active Withdrawn
- 2002-06-13 IL IL15909702A patent/IL159097A0/xx unknown
- 2002-06-13 CA CA002449804A patent/CA2449804A1/en not_active Abandoned
- 2002-06-13 JP JP2003517043A patent/JP4195377B2/ja not_active Expired - Fee Related
- 2002-06-13 PE PE2002000510A patent/PE20030086A1/es not_active Application Discontinuation
- 2002-06-13 MX MXPA03011501A patent/MXPA03011501A/es active IP Right Grant
- 2002-06-13 PL PL02366729A patent/PL366729A1/xx not_active Application Discontinuation
- 2002-06-13 AT AT02791436T patent/ATE343569T1/de not_active IP Right Cessation
- 2002-06-13 WO PCT/EP2002/006488 patent/WO2003011851A2/en not_active Ceased
- 2002-06-13 DE DE60215652T patent/DE60215652T2/de not_active Expired - Fee Related
- 2002-06-13 ES ES02791436T patent/ES2272800T3/es not_active Expired - Lifetime
- 2002-06-13 CZ CZ200425A patent/CZ200425A3/cs unknown
- 2002-06-14 GT GT200200121A patent/GT200200121A/es unknown
2003
- 2003-11-27 ZA ZA200309260A patent/ZA200309260B/en unknown
- 2003-12-10 CO CO03108279A patent/CO5540280A2/es not_active Application Discontinuation
- 2003-12-11 EC EC2003004896A patent/ECSP034896A/es unknown
- 2003-12-12 NO NO20035555A patent/NO20035555D0/no not_active Application Discontinuation
- 2003-12-12 MA MA27440A patent/MA27041A1/fr unknown
- 2003-12-15 BG BG108450A patent/BG108450A/xx unknown
2004
- 2004-05-17 US US10/847,166 patent/US20040214862A1/en not_active Abandoned

Also Published As

Publication number	Publication date
ZA200309260B (en)	2005-02-28
NO20035555D0 (no)	2003-12-12
RU2003137578A (ru)	2005-05-20
AU2002355626B2 (en)	2008-09-25
CN1271066C (zh)	2006-08-23
HUP0401233A3 (en)	2007-05-29
EP1401824A2 (en)	2004-03-31
RS98203A (sr)	2007-02-05
DE60215652D1 (de)	2006-12-07
KR100910958B1 (ko)	2009-08-05
IL159097A0 (en)	2004-05-12
HK1065787A1 (en)	2005-03-04
CA2449804A1 (en)	2003-02-13
CN1516697A (zh)	2004-07-28
US6784173B2 (en)	2004-08-31
ES2272800T3 (es)	2007-05-01
KR20090059172A (ko)	2009-06-10
KR20040018270A (ko)	2004-03-02
ECSP034896A (es)	2004-01-28
CO5540280A2 (es)	2005-07-29
PL366729A1 (en)	2005-02-07
US20030013757A1 (en)	2003-01-16
NZ529874A (en)	2004-12-24
SK172004A3 (en)	2004-07-07
US20040214862A1 (en)	2004-10-28
MA27041A1 (fr)	2004-12-20
HRP20031019A2 (en)	2005-08-31
WO2003011851A3 (en)	2003-09-18
AR036055A1 (es)	2004-08-04
HUP0401233A2 (hu)	2004-10-28
EP1401824B1 (en)	2006-10-25
GT200200121A (es)	2003-06-19
ATE343569T1 (de)	2006-11-15
RU2289580C2 (ru)	2006-12-20
JP2005502641A (ja)	2005-01-27
PE20030086A1 (es)	2003-02-08
JP4195377B2 (ja)	2008-12-10
BR0210424A (pt)	2004-08-17
MXPA03011501A (es)	2004-03-09
WO2003011851A2 (en)	2003-02-13
DE60215652T2 (de)	2007-08-23
PA8548001A1 (es)	2003-01-24
CZ200425A3 (cs)	2004-04-14

Publication	Publication Date	Title
MXPA03011501A (es)	2004-03-09	Derivados aromaticos de acidos dicarboxilicos.
GEP20022678B (en)	2002-04-25	Bicyclic Heteroaromatic Compounds As Protein Tyrosine Kinase Inhibitors, their Pharmaceutical compositions and methods for Treatment
SG148177A1 (en)	2008-12-31	Novel cis-imidazolines
DE60225556D1 (de)	2008-04-24	Dpp-iv-inhibierende purin-derivative zur behandlung von diabetes
MXPA02012272A (es)	2003-04-25	Compuestos heterociclicos que son inhibidores de la enzima dipeptidilpeptidasa-iv.
WO2004037768A3 (en)	2004-07-29	Phenethanolamine derivatives
ATE365720T1 (de)	2007-07-15	Agonisten von beta-adrenorezeptoren
UA74346C2 (uk)	2005-12-15	Похідні амінодикарбонових кислот, їх застосування та лікарський засіб
GT200100183A (es)	2002-05-23	Derivados de quinolina y quinazolina.
MXPA05011707A (es)	2006-02-13	Dihidroquinazolinas sustituidas con propiedades antivirales.
TNSN04203A1 (en)	2007-03-12	Benzoxazinone-derived compounds, their preparation and use as medicaments
UA84407C2 (en)	2008-10-27	Acetyl 2-hydroxy-1,3 diaminoalkanes
WO2002040461A3 (en)	2002-08-01	Aminoalkoxybiphenyl carboxamides as histamine-3 receptor ligands and their therapeutic applications
IL183636A0 (en)	2007-09-20	Quinoline derivative, use and production thereof, and drug containing the same
SI1594885T1 (sl)	2009-06-30	Zdravilo za inhibiranje rasti tumorjev
WO2003006443A3 (de)	2003-05-01	2-`4-(naphtalin-2yl)-thiazol-2-ylaminocarbonyl benzoesäure und 2-`4-(naphtalin-2yl)-pyrimidin-2-ylaminocarbonyl benzoesäure und andere verbindungen als telomerase-hemmer zur anwendung in der tumortherapie
IL162384A0 (en)	2005-11-20	Composition inhibiting matrix-metallproteinases for the treatment of neoplastic diseases
AU2003278667A1 (en)	2004-06-07	Antiinflammatory 3-arylthio-3-thiazolyl-alkylamines
IL163951A (en)	2010-11-30	Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
MX2010003071A (es)	2010-04-01	Uso de n-fenilamidas de acido 2-sulfonilaminobenzoico sustituidas con sulfonilo en el tratamiento del dolor.
UA86399C2 (ru)	2009-04-27	Применение 2,5 дигидроксибензолсульфоновой кислоты для изготовления лекарства, которые применяют для лечения болезней, зависимых от ангиогенеза
ATE252383T1 (de)	2003-11-15	Verwendung von 2-methyl-thiazolidin-2,4- dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen
DE50114181D1 (de)	2008-09-11	Verwendung von 1-phenyl-3-dimethylamino-propan-verbindungen zur therapie der harninkontinenz
TW200502236A (en)	2005-01-16	Novel pyrido[2,3-d]pyrimidin-7-carboxylic acid derivatives, their manufacture and use as pharmaceutical agents
MXPA05009122A (es)	2005-10-20	Derivados de acido benzoilureidopiridil-piperidin-y pirrolidin-carboxilico sustituido, metodo para su produccion y su uso.